Skip to Main Content


Won dismissal of an antitrust suit involving the sale of hundreds of millions of dollars of cancer drugs against a multinational pharmaceutical company and successfully defended the ruling on appeal.

Date: 09.09.22


Stay Up To Date

Subscribe to receive news and insights from WTO.

Sign Up